These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 5840956

  • 21. [Jaundice, chloramphenicol and bone marrow aplasia].
    Medicina (B Aires); 1981; 41(5):587-95. PubMed ID: 7345336
    [No Abstract] [Full Text] [Related]

  • 22. [Is Myleran (busulfan) a leukemogenic substance?].
    Hunstein W.
    Schweiz Med Wochenschr; 1965 Oct 23; 95(43):1437-9. PubMed ID: 5880927
    [No Abstract] [Full Text] [Related]

  • 23. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases.
    Polak BC, Wesseling H, Schut D, Herxheimer A, Meyler L.
    Acta Med Scand; 1972 Nov 23; 192(5):409-14. PubMed ID: 5083381
    [No Abstract] [Full Text] [Related]

  • 24. [Bone marrow insufficiency and dyserythropoiesis in chronic liver disease].
    Hernández Nieto L, Batista López JN, Brito Barroso ML, Ravina Cabrera M, Santolaria Fernández FJ, González Brito G.
    Sangre (Barc); 1982 Nov 23; 27(4-B):589-603. PubMed ID: 7157134
    [No Abstract] [Full Text] [Related]

  • 25. Bone marrow depression induced by chloramphenicol or phenylbutazone. Leukemia and other sequelae.
    Fraumeni JF.
    JAMA; 1967 Sep 11; 201(11):828-34. PubMed ID: 6071896
    [No Abstract] [Full Text] [Related]

  • 26. [Pancytopenia following acute hepatitis].
    Schwabel HJ, Hartwich G.
    Med Klin; 1971 Feb 19; 66(8):276-81. PubMed ID: 5552236
    [No Abstract] [Full Text] [Related]

  • 27. Aplastic anemia: the disease and its management.
    Casale TB.
    Postgrad Med; 1982 Apr 19; 71(4):59-70. PubMed ID: 7041101
    [Abstract] [Full Text] [Related]

  • 28. [Etiopathogenetic, clinical and therapeutic aspects of involutive myelopathies].
    Corneo G, Cortellaro M, Maiolo AT, Bardi U.
    Recenti Prog Med; 1973 Jan 19; 54(1):44-76. PubMed ID: 4121165
    [No Abstract] [Full Text] [Related]

  • 29. [Cytopenia due to drugs].
    Serban-Pârâu G, Gociu M.
    Med Interna (Bucur); 1971 Jan 19; 23(1):61-8. PubMed ID: 5550275
    [No Abstract] [Full Text] [Related]

  • 30. Toxic effects of chloramphenicol. A survey of children treated in general practice.
    Yodfat Y.
    Isr J Med Sci; 1969 Jan 19; 5(6):1184-7. PubMed ID: 5367443
    [No Abstract] [Full Text] [Related]

  • 31. [Current aspects of iatrogenic lesions of the bone marrow].
    Hausmann K, Skrandies G, Sachtleben P.
    Minerva Med; 1976 Nov 14; 67(55):3583-90. PubMed ID: 995304
    [Abstract] [Full Text] [Related]

  • 32. [Pancytopenia following viral hepatitis].
    Siegmund H.
    Med Klin; 1969 Jun 06; 64(23):1073-5. PubMed ID: 5808896
    [No Abstract] [Full Text] [Related]

  • 33. [Acquired panmyelopathies].
    Keiser G.
    Schweiz Med Wochenschr; 1970 Nov 14; 100(46):1938-48. PubMed ID: 5507832
    [No Abstract] [Full Text] [Related]

  • 34. Phenylalanine and chloramphenicol.
    Nahum LH.
    Conn Med; 1966 Feb 14; 30(2):102-5. PubMed ID: 5904063
    [No Abstract] [Full Text] [Related]

  • 35. [Toxic bone-marrow insufficiency].
    Speck B.
    Hamatol Bluttransfus; 1975 Feb 14; 16():235-44. PubMed ID: 1193443
    [No Abstract] [Full Text] [Related]

  • 36. Aplastic anemia and chloramphenicol.
    KELSEY FE.
    SD J Med Pharm; 1953 Mar 14; 6(3):65-6; passim. PubMed ID: 13038511
    [No Abstract] [Full Text] [Related]

  • 37. Drug--induced bone marrow injury.
    Yunis AA.
    Adv Intern Med; 1969 Mar 14; 15():357-76. PubMed ID: 4908623
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.